146 related articles for article (PubMed ID: 30186591)
1. TIPE2 acts as a biomarker for tumor aggressiveness and suppresses cell invasiveness in papillary thyroid cancer (PTC).
Jia W; Li Z; Chen J; Sun L; Liu C; Wang S; Chi J; Niu J; Lai H
Cell Biosci; 2018; 8():49. PubMed ID: 30186591
[TBL] [Abstract][Full Text] [Related]
2. TIPE2 suppresses angiogenesis and non-small cell lung cancer (NSCLC) invasiveness via inhibiting Rac1 activation and VEGF expression.
Li Z; Guo C; Liu X; Zhou C; Zhu F; Wang X; Wang Q; Shi Y; Wang J; Zhao W; Zhang L
Oncotarget; 2016 Sep; 7(38):62224-62239. PubMed ID: 27556698
[TBL] [Abstract][Full Text] [Related]
3. TIPE2 acts as a biomarker for GIST risk category and suppresses the viability and invasiveness of GIST cells.
Li Z; Zhang W; Li Y; Cao S; Liu S; Ning L; Jiao X; Liu Z; Xing X; Li Y; Zhou Y
Cell Biosci; 2018; 8():62. PubMed ID: 30534358
[TBL] [Abstract][Full Text] [Related]
4. Human tumor necrosis factor (TNF)-alpha-induced protein 8-like 2 suppresses hepatocellular carcinoma metastasis through inhibiting Rac1.
Cao X; Zhang L; Shi Y; Sun Y; Dai S; Guo C; Zhu F; Wang Q; Wang J; Wang X; Chen YH; Zhang L
Mol Cancer; 2013 Nov; 12(1):149. PubMed ID: 24274578
[TBL] [Abstract][Full Text] [Related]
5. TIPE2 Overexpression Suppresses the Proliferation, Migration, and Invasion in Prostate Cancer Cells by Inhibiting PI3K/Akt Signaling Pathway.
Lu Q; Liu Z; Li Z; Chen J; Liao Z; Wu WR; Li YW
Oncol Res; 2016; 24(5):305-313. PubMed ID: 27712587
[TBL] [Abstract][Full Text] [Related]
6. TIPE2 functions as a metastasis suppressor via negatively regulating β-catenin through activating GSK3β in gastric cancer.
Wu J; Zhang H; Xu C; Xu H; Zhou X; Xie Y; Tao M
Int J Oncol; 2016 Jan; 48(1):199-206. PubMed ID: 26530498
[TBL] [Abstract][Full Text] [Related]
7. TIPE‑2 suppresses growth and aggressiveness of hepatocellular carcinoma cells through downregulation of the phosphoinositide 3‑kinase/AKT signaling pathway.
Wang L; Chen C; Feng S; Tian J
Mol Med Rep; 2018 May; 17(5):7017-7026. PubMed ID: 29568863
[TBL] [Abstract][Full Text] [Related]
8. TIPE2 protein prevents injury-induced restenosis in mice.
Zhang G; Zhao L; Wang Y; Shao J; Cui J; Lou Y; Geng M; Zhang N; Chen YH; Liu S
Biochim Biophys Acta; 2015 Aug; 1852(8):1574-84. PubMed ID: 25912734
[TBL] [Abstract][Full Text] [Related]
9. Immune Negative Regulator TIPE2 Inhibits Cervical Squamous Cancer Progression Through Erk1/2 Signaling.
Huang LQ; Zheng B; He Y
Open Life Sci; 2019 Jan; 14():528-536. PubMed ID: 33817189
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-directed expression of TIPE2 suppresses gastric cancer growth via induction of apoptosis and inhibition of AKT and ERK1/2 signaling.
Zhu Y; Tao M; Wu J; Meng Y; Xu C; Tian Y; Zhou X; Xiang J; Zhang H; Xie Y
Cancer Gene Ther; 2016 Apr; 23(4):98-106. PubMed ID: 26987289
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated TIPE2 overexpression inhibits gastric cancer metastasis via reversal of epithelial-mesenchymal transition.
Yin H; Huang X; Tao M; Hu Q; Qiu J; Chen W; Wu J; Xie Y
Cancer Gene Ther; 2017 Apr; 24(4):180-188. PubMed ID: 28186089
[TBL] [Abstract][Full Text] [Related]
12. Tumor Necrosis Factor (TNF)-α-Induced Protein 8-like-2 (TIPE2) Inhibits Proliferation and Tumorigenesis in Breast Cancer Cells.
Wang K; Ren Y; Liu Y; Zhang J; He JJ
Oncol Res; 2017 Jan; 25(1):55-63. PubMed ID: 28081733
[TBL] [Abstract][Full Text] [Related]
13. TIPE2 suppresses the tumorigenesis, growth and metastasis of breast cancer via inhibition of the AKT and p38 signaling pathways.
Zhang Z; Liu L; Liu C; Cao S; Zhu Y; Mei Q
Oncol Rep; 2016 Dec; 36(6):3311-3316. PubMed ID: 27779698
[TBL] [Abstract][Full Text] [Related]
14. Tumour necrosis factor-α-induced protein 8-like 2 is a novel regulator of proliferation, migration, and invasion in human rectal adenocarcinoma cells.
Wu DD; Liu SY; Gao YR; Lu D; Hong Y; Chen YG; Dong PZ; Wang DY; Li T; Li HM; Ren ZG; Guo JC; He F; Ren XQ; Sun SY; Duan SF; Ji XY
J Cell Mol Med; 2019 Mar; 23(3):1698-1713. PubMed ID: 30637920
[TBL] [Abstract][Full Text] [Related]
15. TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway.
Zhu L; Zhang X; Fu X; Li Z; Sun Z; Wu J; Wang X; Wang F; Li X; Niu S; Ding M; Yang Z; Yang W; Yin M; Zhang L; Zhang M
J Transl Med; 2018 Jan; 16(1):7. PubMed ID: 29343267
[TBL] [Abstract][Full Text] [Related]
16. TIPE2 Suppresses Malignancy of Pancreatic Cancer Through Inhibiting TGFβ1 Mediated Signaling Pathway.
Feng F; Liu C; Bian H; Cai W; Zhou Y; Zhou L; Zhuang Z
Front Oncol; 2021; 11():680985. PubMed ID: 34249724
[TBL] [Abstract][Full Text] [Related]
17. TIPE2 Inhibits Hypoxia-Induced Wnt/β-Catenin Pathway Activation and EMT in Glioma Cells.
Liu ZJ; Liu HL; Zhou HC; Wang GC
Oncol Res; 2016; 24(4):255-61. PubMed ID: 27656836
[TBL] [Abstract][Full Text] [Related]
18. TIPE2 suppresses progression and tumorigenesis of the oral tongue squamous cell carcinoma by regulating FoxP3
Zhao LL
J Bioenerg Biomembr; 2020 Aug; 52(4):279-289. PubMed ID: 32594290
[TBL] [Abstract][Full Text] [Related]
19. TIPE2 inhibits TNF-α-induced hepatocellular carcinoma cell metastasis via Erk1/2 downregulation and NF-κB activation.
Zhang YH; Yan HQ; Wang F; Wang YY; Jiang YN; Wang YN; Gao FG
Int J Oncol; 2015 Jan; 46(1):254-64. PubMed ID: 25339267
[TBL] [Abstract][Full Text] [Related]
20. Up-regulating TIPE2 alleviates inflammatory pain by suppressing microglial activation-mediated inflammatory response via inhibiting Rac1/NF-κB pathway.
Sun X; Li X; Zhou Y; Wang Y; Liu X
Exp Cell Res; 2021 Jul; 404(1):112631. PubMed ID: 33933441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
